{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:19:42Z","timestamp":1771064382278,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006521","name":"School of Medicine, Stanford University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006521","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.gore.2020.100595","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T19:37:15Z","timestamp":1591213035000},"page":"100595","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The role of asymptomatic screening in the detection of recurrent ovarian cancer"],"prefix":"10.1016","volume":"33","author":[{"given":"M.T.","family":"Richardson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Routson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Karam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Dorigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Renz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.J.","family":"Diver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.gore.2020.100595_b0005","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ygyno.2008.04.030","article-title":"The role of regular physical examination in the detection of ovarian cancer recurrence","volume":"110","author":"Chan","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"20","key":"10.1016\/j.gore.2020.100595_b0010","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa1902626","article-title":"Secondary surgical cytoreduction for recurrent ovarian cancer","volume":"381","author":"Coleman","year":"2019","journal-title":"N Engl. J. Med."},{"issue":"10","key":"10.1016\/j.gore.2020.100595_b0015","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/1471-0528.12289","article-title":"Simulation training for breast and pelvic physical examination: a systematic review and meta-analysis","volume":"120","author":"Dilaveri","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.gore.2020.100595_b0020","doi-asserted-by":"crossref","unstructured":"Du Bois, A., Vergote, I., Ferron, G., Reuss, A., Meier, W., Greggi, S., et al. Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III\/ENGOT ov20. Journal of Clinical Oncology. 2017 35:15_suppl, 5501-5501.","DOI":"10.1200\/JCO.2017.35.15_suppl.5501"},{"issue":"6","key":"10.1016\/j.gore.2020.100595_b0025","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/oby.2009.481","article-title":"Family physicians' barriers to cancer screening in extremely obese patients","volume":"18","author":"Ferrante","year":"2010","journal-title":"Obesity (Silver Spring)."},{"issue":"3","key":"10.1016\/j.gore.2020.100595_b0030","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/IGC.0b013e3181a1cc02","article-title":"Are surveillance procedures of clinical benefit for patients treated for ovarian cancer? A retrospective Italian multicentric study","volume":"19","author":"Gadducci","year":"2009","journal-title":"Int. J. Gynecol. Can."},{"issue":"11","key":"10.1016\/j.gore.2020.100595_b0035","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1097\/00001888-200311000-00019","article-title":"Pelvic examination training for interns: a randomized controlled trial","volume":"78","author":"Herbers","year":"2003","journal-title":"Acad Med."},{"issue":"1","key":"10.1016\/j.gore.2020.100595_b0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ygyno.2006.02.005","article-title":"Follow-up of ovarian and primary peritoneal carcinoma: the value of physical examination in patients with pretreatment elevated CA125 levels","volume":"103","author":"Menczer","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"7373","key":"10.1016\/j.gore.2020.100595_b0045","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/bmj.325.7373.1145","article-title":"Nurse led follow up and conventional medical follow up in management of patients with lung cancer: randomised trial","volume":"325","author":"Moore","year":"2002","journal-title":"BMJ"},{"issue":"11 Suppl 2","key":"10.1016\/j.gore.2020.100595_b0050","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1111\/IGC.0b013e3181f63a28","article-title":"What surveillance plan should be advised for patients in remission after completion of first-line therapy for advanced ovarian cancer?","volume":"20","author":"Rustin","year":"2010","journal-title":"Int. J. Gynecol. Can."},{"issue":"9747","key":"10.1016\/j.gore.2020.100595_b0055","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(10)61268-8","article-title":"Early versus delayed treatment of relapsed ovarian cancer (MRC OV05\/EORTC 55955): a randomised trial","volume":"376","author":"Rustin","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gore.2020.100595_b0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2017.03.022","article-title":"An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations","volume":"146","author":"Salani","year":"2017","journal-title":"Gynecol Oncol."},{"issue":"2","key":"10.1016\/j.gore.2020.100595_b0065","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ygyno.2010.01.014","article-title":"Surveillance for the detection of recurrent ovarian cancer: survival impact or lead-time bias?","volume":"117","author":"Tanner","year":"2010","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.gore.2020.100595_b0070","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejogrb.2003.10.029","article-title":"Post-therapy surveillance and after-care in ovarian cancer","volume":"114","author":"von Georgi","year":"2004","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"9","key":"10.1016\/j.gore.2020.100595_b0075","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-132-9-200005020-00003","article-title":"Screening for cervical and breast cancer: is obesity an unrecognized barrier to preventive care?","volume":"132","author":"Wee","year":"2000","journal-title":"Ann. Int. Med."}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578920300618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578920300618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T01:55:43Z","timestamp":1762480543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578920300618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":15,"alternative-id":["S2352578920300618"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2020.100595","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of asymptomatic screening in the detection of recurrent ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2020.100595","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100595"}}